Reference
Lacout C, et al. R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment: A eight-year trajectory study. European Journal of Haematology 105: 223-230, No. 2, Aug 2020. Available from: URL: http://doi.org/10.1111/ejh.13429
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1818, 41 (2020). https://doi.org/10.1007/s40278-020-82321-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-82321-7